Evidence map›Paper›PMID 22612440›Full record

ReviewSurgical infections2012

Disseminated Nocardia farcinica: literature review and fatal outcome in an immunocompetent patient.

Jonathan M Budzik, Mojgan Hosseini, Alexander C Mackinnon, Jerome B Taxy

Abstract readCase ReportsReview
In one paragraph

Review in Surgical infections, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 68 citations in OpenAlex.

  1. Article
  2. Article
  3. A Rare Case of Coinfection ofInfection and drug resistance · 2025
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Disseminated Nocardiosis Caused byVeterinary sciences · 2022
    Article
  11. Immunoprotective Analysis of the NFA49590 Protein fromPathogens (Basel, Switzerland) · 2022
    Article
  12. Article
  13. Cerebellious abscesses caused by Nocardia farcinica in an immunocompromised patient.Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2022
    Article
  14. Article
  15. Article
  16. Article
  17. A case report of brain abscess caused by Nocardia farcinica.European journal of medical research · 2021
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Jonathan M BudzikDepartment of Pathology, Pritzker School of Medicine, Chicago, Illinois, USA.
Mojgan Hosseini
Alexander C Mackinnon
Jerome B Taxy
University of Chicago Medical Center · USMedical College of Wisconsin · US

Funding

MEDICAL SCIENTIST TRAININGT32GM007281 · NIGMS · UNIVERSITY OF CHICAGO · PI CLARK, MARCUS RAMSAY · 1985 to 2022
$32.1M
NIGMS NIH HHS GM07281
6 · The paper itself

Abstract

backgroundNocardia farcinica is a gram-positive, partially acid-fast, methenamine silver-positive aerobic actinomycete. Nocardia spp. are opportunistic pathogens, and N. farcinica is the least common species of clinical importance.

methodsReview of the recent literature and description of a immunocompetent patient with no known risk factors who contracted fatal N. farcinica sepsis.

resultsPositive pre-mortem and post-mortem cultures from the lung and synovium correlated with acute bronchopneumonia and synovitis at autopsy. Colonies of filamentous bacteria, which were not apparent in conventional hematoxylin and eosin-stained sections, were observed with gram and methenamine silver stains, but acid-fast stains were negative. A literature review revealed that disseminated N. farcinica often is associated with an underlying malignant tumor or autoimmune disease (88% of patients). Chemotherapy or corticosteroid treatments are additional risk factors.

conclusionsTrimethoprim-sulfamethoxazole typically is the first-line therapy for N. farcinica; treatment with amikacin and imipenem-cilastatin is used less often (7% of patients). Despite aggressive therapy, we observed that the death rate (39%) associated with N. farcinica in recent publications was eight percentage points higher than reported in a review from 2000.

Indexed as

ImmunocompetenceAgedAnti-Infective AgentsFatal OutcomeHumansMaleNocardia InfectionsPneumonia, BacterialSynovitisTrimethoprim, Sulfamethoxazole Drug CombinationAnti-Infective AgentsTrimethoprim, Sulfamethoxazole Drug Combination

Identifiers

PMID22612440
PMCPMC3375863
OpenAlexW2091145348

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.